Literature DB >> 24642674

Gynaecological cancer: MITO-7-a weekly regimen associated with a better quality of life for patients with advanced ovarian cancer.

Alessia Errico.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24642674     DOI： 10.1038/nrclinonc.2014.45

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

Authors:  Sandro Pignata; Giovanni Scambia; Dionyssios Katsaros; Ciro Gallo; Eric Pujade-Lauraine; Sabino De Placido; Alessandra Bologna; Beatrice Weber; Francesco Raspagliesi; Pierluigi Benedetti Panici; Gennaro Cormio; Roberto Sorio; Maria Giovanna Cavazzini; Gabriella Ferrandina; Enrico Breda; Viviana Murgia; Cosimo Sacco; Saverio Cinieri; Vanda Salutari; Caterina Ricci; Carmela Pisano; Stefano Greggi; Rossella Lauria; Domenica Lorusso; Claudia Marchetti; Luigi Selvaggi; Simona Signoriello; Maria Carmela Piccirillo; Massimo Di Maio; Francesco Perrone
Journal:  Lancet Oncol       Date:  2014-02-28       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.